The toxicogenomic study on Persistent Organic Pollutants (POPs) in human hepatoma cell line

Biochip Journal

Volumn 7, Issue 1, 2013, Pages 17-28

  Choi, Han Saem ^a,b   Song, Mi Kyung ^a   Lee, EunIl ^b   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Chlordane; Gene ontology (GO); Microarray; Mirex; Persistent Organic Pollutants (POPs); Toxaphene

Indexed keywords

BIOCHEMISTRY; CELL CULTURE; CELL DEATH; GENE EXPRESSION; INSECTICIDES; MICROARRAYS; RISK ASSESSMENT; TOXICITY;

CHLORDANE; GENE ONTOLOGY; MIREX; PERSISTENT ORGANIC POLLUTANTS; TOXAPHENE;

ORGANIC POLLUTANTS;

CAMPHECLOR; CHLORDANE; MIREX;

APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL CYCLE REGULATION; CELL LINE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER TOXICITY; NUCLEOTIDE SEQUENCE; ORGANIC POLLUTION; PREDICTION; TOXICOGENETICS; UNINDEXED SEQUENCE; UPREGULATION; XENOBIOTIC METABOLISM;

EID: 84875315910     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-013-7104-0     Document Type: Article

References (49)

1. Namieśnik, J., Zabiegała, B., Kot-Wasik, A., Partyka, M. & Wasik, A. Passive sampling and/or extraction techniques in environmental analysis: a review. Anal. Bioanal. Chem. 381, 279-301 (2005).
2. van den Berg, M. et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93, 223-241 (2006).
3. Porta, M. et al. Monitoring concentrations of persistent organic pollutants in the general population: the international experience. Environ. Int. 34, 546-561 (2007).
4. United Nations Environment Programme UNEP (2003).
5. Webster, E., Mackay, D. & Wania, F. Evaluating environmental persistence. Environ. Toxicol. Chem. 17, 2148-2158 (1998).
6. Dickerson, S. M. & Gore, A. C. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle. Rev. Endocr. Metab. Disord. 8, 143-159 (2007).
7. Ribas-Fitó, N., Sala, M., Kogevinas, M. & Sunyer, J. Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J. Epidemiol. Community Health55, 537-546 (2001).
8. Snedeker, S. M. Pesticides and breast cancer risk: a review of DDT, DDE, and Dieldrin. Environ. Health Perspect. 109, 35-47 (2001).
9. De Jager, C. et al. Reduced seminal parameters associated with environmental DDT exposure and p, p′-DDE concentrations in men in Chiapas, Mexico: a cross sectional study. J. Androl. 27, 16-27 (2006).
10. Lee, D. H. et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care29, 1638-1644 (2006).
11. Daston, G. et al. A framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspect. 112, 238-256 (2004).
12. Chevrier, J., Eskenazi, B., Bradman, A., Fenster, L. & Barr, D. B. Associations between prenatal exposure to polychlorinated biphenyls and neonatal thyroid-stimulating hormone levels in a Mexican-American population, Salinas Valley, California. Environ. Health Perspect. 115, 1490-1496 (2007).
13. Eskenazi, B. et al. Pesticide toxicity and the developing brain. Basic Clin. Pharmacol. Toxicol. 102, 228-236 (2008).
14. Song, M. K., Song, M., Choi, H. S. & Ryu, J. C. Benzo [k]fluoranthene-Induced Changes in miRNA-mRNA Interactions in Human Hepatocytes. Toxicol. Environ. Health Sci. 4, 143-153 (2012).
15. 2 nanometer-sized photocatalysts. Mol. Cell. Toxicol. 8, 127-137 (2012).
16. Aardema, M. J. & MacGregor, J. T. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat. Res. 499, 13-25 (2002).
17. Iida, M. et al. Correlation between Bcl-2 overexpression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C3F1 mouse. Toxicol. Sci. 56, 297-302 (2000).
18. Takeda, Y. et al. Spontaneous regression of hepatocellular carcinoma and review of literature. J. Gastroenterol. Hepatol. 15, 1079-1086 (2000).
19. Ikeda, M., Okada, S., Ueno, H., Okusaka, T. & Kuriyama, H. Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: a case report. Jpn. J. Clin. Oncol. 31, 454-458 (2001).
20. Aseni, P. et al. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J. Clin. Gastroenterol. 33, 234-236 (2001).
21. Velazquez, I. & Alter, B. P. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am. J. Hematol. 77, 257-267 (2004).
22. Bursch, W. et al. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol. Sci. 85, 515-529 (2005).
23. Herrera, B. et al. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med. 36, 16-26 (2004).
24. Hansen, M. E. & Matsumura, F. Effects of heptachlor epoxide on components of various signal transduction pathways important in tumor promotion in mouse hepatoma cells. Determination of the most sensitive tumor promoter related effect induced by heptachlor epoxide. Toxicology160, 139-153 (2001).
25. Aasen, T., Hodgins, M. B., Edward, M. & Graham, S. V. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression. Oncogene22, 7969-7980 (2003).
26. Bifulco, K. et al. An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor. FEBS Lett. 582, 1141-1146 (2008).
27. Li, J. et al. The Plasminogen Activator/Plasmin System Is Essential for Development of the Joint Inflammatory Phase of Collagen Type II-Induced Arthritis. Am. J. Pathol. 166, 783-792 (2005).
28. Okazaki, I., Watanabe, T., Hozawa, S., Arai, M. & Maruyama, K. Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. J. Gastroenterol. Hepatol. 15, D26-D32 (2000).
29. Lijnen, H. R. & Collen, D. Matrix metalloproteinase system deficiencies and matrix degradation. Thromb. Haemost. 82, 837-845 (1999).
30. Heymans, S. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5, 1135-1142 (1999).
31. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cell. Nature335, 440-442 (1988).
32. Fanidi, A., Harrington, E. A. & Evan, G. I. Cooperative interaction between cmyc and bcl-2 proto-oncogenes. Nature359, 554-556 (1992).
33. Shimizu, S. et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature374, 811-813 (1996).
34. Zhou, H. M., Bolon, I., Nichols, A., Wohlwend, A. & Vassalli, J. D. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res. 61, 970-976 (2001).
35. Luo, D., Cheng, S. C., Xie, H. & Xie, Y. Effect of Bcl-2 and Bcl-xL protein levels on chemoresistance of hepatoblastoma HepG2 cell line. Biochem. Cell. Biol. 78, 119-126 (2000).
36. Julen, N. et al. In vitro biosynthesis of complement factor I by human endothelial cells. Eur. J. Immunol. 22, 213-217 (1992).
37. Guc, D. et al. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol. Int. 13, 136-146 (1993).
38. Thornton, B. P., Vetvicka, V. & Ross, G. D. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104, 531-537 (1996).
39. Fischer, M. B. et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. Carroll. J. Immunol. 157, 549-556 (1996).
40. Gribenko, A. V., Hopper, J. E. & Makhatadze, G. I. Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins. Biochemistry40, 15538-15548 (2001).
41. Sakaguchi, M. et al. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J. Cell. Biol. 149, 1193-1206 (2000).
42. Sakaguchi, M. et al. Loss of nuclear localization of the S100C protein in immortalized human fibroblasts. Radiat. Res. 155, 208-214 (2001).
43. Yao, R. et al. The S100 proteins for screening and prognostic grading of bladder cancer. Histol. Histopathol. 22, 1025-1032 (2007).
44. Sakaguchi, M., Miyazaki, M., Kondo, T. & Namba, M. Upregulation of S100C in normal human fibroblasts in the process of aging in vitro. Exp. Gerontol. 36, 1317-1325 (2001).
45. Hirokawa, N., Noda, Y. & Okada, Y. Kinesin and dynein superfamily proteins in organelles transport and cell division. Curr. Opin. Cell. Biol. 10, 60-73 (1998).
46. Echard, A. et al. Interaction of a Golgi associated kinesin-like protein with rab6. Science279, 580-585 (1998).
47. Hill, E., Clarke, M. & Barr, F. A. The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. EMBO J. 19, 5711-5719 (2000).
48. Fontijn, R. D. et al. The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis. Mol. Cell. Biol. 21, 2944-2955 (2001).
49. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA98, 5116-5121 (2001).